Fast Acting Triflex Tablets
Natural health product licensed in Canada
- Licence holder
- GNC Canada Holdings ULC
- NPN or DIN-HM
- 80027069
- Status
- Inactive licence
- Licence date
- 24 August 2011
- Revision date
- 5 July 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 7.5 milligramme | 30,000 µg |
| Acide hyaluronique Source : Sodium hyaluronate from bacterial extracellular capsule of Streptococcus equi | 1.25 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Sulfate de chondroïtine de sodium/ sulfate de chondroïtine sodique provenant des cartilages bovins | 300 milligramme | Not calculated |
| Scutellaria baicalensis Source : Racine | 50 milligramme | Not calculated |
Non-medicinal ingredients
Crospovidone, Poly(éthylène glycol), Saveur de vanille naturelle, Microcrystalline cellulose, Dioxyde de titane, (p)-hydroxybenzoate de propyle, Maltodextrine, Acétoglycérides, Cire de Carnauba, Riboflavine, Dioxyde de silicium, Stéarate de magnésium végétal, Croscarmellose de sodium, Poly(sorbate) 80, Sucralose, Hypromellose, (p)-hydroxybenzoate de méthyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. A factor in maintaining healthy cartilage. Helps to maintain healthy cartilage. A factor in maintaining joint health. Helps to maintain joint health. Helps in the development and maintenance of bones and cartilage.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80027069
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging